ÂÜÀòÂÒÂ×

Tom Sun is Vice President, Strategic Consulting Services, Cognigen Division at Simulations Plus. Dr. Sun has more than twenty years of pharmaceutical industry experience at Genentech (1998-2002), ALZA/Johnson & Johnson (2002-2004), Amgen (2004-2015), and Janssen (2015-2022). Prior to this current role, Dr. Sun was the Oncology Therapeutic Area Head, Clinical Pharmacology & Pharmacometrics Department and the Licensing & Acquisition Evaluation Head, Quantitative Sciences at Janssen R&D.

Dr. Sun received his B.S. in Pharmacy from Taipei Medical University (formerly known as Taipei Medical College) and his Ph.D. in Pharmaceutical Sciences from the University at Buffalo. He is specialized in translational Pharmacokinetic/Pharmacodynamic (PK/PD) research, Clinical Pharmacology, Modeling & Simulations, and product registration for small molecules, biologics, and CAR-T therapies. His recent research focus has been the application of model-based drug development in oncology. Dr. Sun has authored more than 40 peer reviewed articles and book chapter, and is an invited reviewer for eight scientific journals in the field of Clinical Pharmacology and PK/PD.